HIV and AIDS

This monograph is a toolkit for planning and implementing antiretroviral (ARV) treatment programs in resource-limited settings by providing technical guidance on planning treatment programs. It lists the goals of an ARV treatment program as reducing illnesses and death due to HIV/AIDS, providing safe and effective treatment, working towards providing universal access to treatment, making the best possible use of resources, and integrating ARV treatment with other public health resources.

This serial is a newsletter that reports on the corporate philantropic response to HIV in the United States and globally. This issue discusses the World Economic Forum's Global Health Initiative (GHI), the Henry J. Kaiser Family Foundation and Viacom's 'Know HIV/AIDS' global media campaign to combat HIV/AIDS, the Design Industries Fighting AIDS (DIFFA) program, the ways in which companies are helping to fund the fight against HIV/AIDS, and a report on the Global Business Coalition on HIV/AIDS (GBC).

This report presents the case study of the Lighthouse Trust in Malawi, which was established to provide quality care and counseling and to improve the quality of life of persons with HIV/AIDS, including the terminally ill. The report describes the objective of the Lighthouse, its services, management, staffing, funding, community involvement, building facilities, diagnostic services, antiretroviral treatment implementation, clients served, adherence support strategies, clinical outcomes, added improvements, and lessons learned.

This report presents guidelines for monitoring programs for the prevention of HIV/AIDS in infants and young children. It presents a list of core indicators and additonal indicators for indicating the success of these programs. Countries with prevention programs for infants and young children should have the core indicators in operation. The report gives a definition of each indicator, the rationale for its use, what it measures, measurement tools and how the indicator is measured, and its strengths and limitations.

This report presents recommendations for preventing and controlling infectious diseases and managing personnel health and safety concerns and infection control in dental care settings. The report updates and revises previous CDC recommendations and incorporates infection-control measures.

This report is a case study of Cuba’s response to HIV. The report presents the background information on Cuba’s initial response to the HIV/AIDS epidemic, the establishment of AIDS sanatoria from 1986-1993 for taking care of HIV positive persons, the institution of an ambulatory care system for HIV treatment of people who want to remain at home, and introduction of antiretroviral (ART) treatment in 1996. Cuba began producing its own antiretrovirals in 2001, and 100% ART treatment was achieved in 2003. The report lists the drugs and regimens used in Cuba and the criteria to initiate ART.

This pamphlet discusses the risk of exposure to HIV during emergency situations such as war, civil strife, disasters or epidemics, since many of the conditions that facilitate the spread of HIV are present in emergencies.

This information sheet presents the federal budget request for domestic and global HIV/AIDS funding for fiscal year (FY) 2005. The budget request shows a $1.3 billion increase over 2004. The sheet explains the general funding categories and factors driving the budget increase. The fund categories are care, cash and housing assistance, prevention, research, and global. A chart of Federal funding for HIV/AIDS from FY 2003-2005 is provided.

This report describes the Drug Resources Enhancement Against AIDS and Malnutrition (DREAM) project in Mozambique. DREAM was created by the religious community of Sant’ Egidio in Rome. The main objective was to provide diagnosis and comprehensive treatment, prevention of perinatal transmission and of HIV transmission in the population through community care and home care services and mother and child prevention and care. The project uses a holistic approach by treating HIV with highly active antiretroviral therapy (HAART) as well as treating malnutrition, TB, malaria, and STDs.